These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36148156)

  • 1. Daily online contouring and re-planning versus translation-only correction in neurovascular-sparing magnetic resonance-guided radiotherapy for localized prostate cancer.
    Teunissen FR; van der Voort van Zyp JRN; de Groot-van Breugel EN; Verkooijen HM; Wortel RC; de Boer JCJ
    Phys Imaging Radiat Oncol; 2022 Oct; 24():43-46. PubMed ID: 36148156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interrater agreement of contouring of the neurovascular bundles and internal pudendal arteries in neurovascular-sparing magnetic resonance-guided radiotherapy for localized prostate cancer.
    Teunissen FR; Wortel RC; Wessels FJ; Claes A; van de Pol SMG; Rasing MJA; Meijer RP; van Melick HHE; de Boer JCJ; Verkooijen HM; van der Voort van Zyp JRN
    Clin Transl Radiat Oncol; 2022 Jan; 32():29-34. PubMed ID: 34825071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptive magnetic resonance-guided neurovascular-sparing radiotherapy for preservation of erectile function in prostate cancer patients.
    Teunissen FR; Wortel RC; Hes J; Willigenburg T; de Groot-van Breugel EN; de Boer JCJ; van Melick HHE; Verkooijen HM; van der Voort van Zyp JRN
    Phys Imaging Radiat Oncol; 2021 Oct; 20():5-10. PubMed ID: 34604553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurovascular-Sparing MR-Guided Adaptive Radiotherapy in Prostate Cancer; Defining the Potential Population for Erectile Function-Sparing Treatment.
    Teunissen FR; van der Voort van Zyp JRN; Verkooijen HM; Wortel RC
    J Sex Med; 2022 Jul; 19(7):1196-1200. PubMed ID: 35618631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric feasibility of neurovascular bundle-sparing stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer to preserve erectile function.
    Hwang ME; Mayeda M; Shaish H; Elliston CD; Spina CS; Wenske S; Deutsch I
    Br J Radiol; 2021 Mar; 94(1119):20200433. PubMed ID: 33586999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurovascular bundle-sparing radiotherapy for prostate cancer using MRI-CT registration: A dosimetric feasibility study.
    Cassidy RJ; Yang X; Liu T; Thomas M; Nour SG; Jani AB
    Med Dosim; 2016 Winter; 41(4):339-343. PubMed ID: 27745996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep learning for automated contouring of neurovascular structures on magnetic resonance imaging for prostate cancer patients.
    van den Berg I; Savenije MHF; Teunissen FR; van de Pol SMG; Rasing MJA; van Melick HHE; Brink WM; de Boer JCJ; van den Berg CAT; van der Voort van Zyp JRN
    Phys Imaging Radiat Oncol; 2023 Apr; 26():100453. PubMed ID: 37312973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vessel-sparing prostate radiotherapy: dose limitation to critical erectile vascular structures (internal pudendal artery and corpus cavernosum) defined by MRI.
    McLaughlin PW; Narayana V; Meirovitz A; Troyer S; Roberson PL; Gonda R; Sandler H; Marsh L; Lawrence T; Kessler M
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):20-31. PubMed ID: 15629590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose optimization and endorectal balloon for internal pudendal arteries sparing in prostate SBRT.
    Jaccard M; Lamanna G; Dubouloz A; Rouzaud M; Miralbell R; Zilli T
    Phys Med; 2019 May; 61():28-32. PubMed ID: 31151576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implementation of magnetic resonance imaging guided adaptive radiotherapy for localized prostate cancer.
    Tetar SU; Bruynzeel AME; Lagerwaard FJ; Slotman BJ; Bohoudi O; Palacios MA
    Phys Imaging Radiat Oncol; 2019 Jan; 9():69-76. PubMed ID: 33458428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First 500 Fractions Delivered with a Magnetic Resonance-guided Radiotherapy System: Initial Experience.
    Sahin B; Zoto Mustafayev T; Gungor G; Aydin G; Yapici B; Atalar B; Ozyar E
    Cureus; 2019 Dec; 11(12):e6457. PubMed ID: 32025388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of Adaptive MR-guided Stereotactic Body Radiotherapy (SBRT) of Lung Tumors.
    Padgett KR; Simpson GN; Llorente R; Samuels MA; Dogan N
    Cureus; 2018 Apr; 10(4):e2423. PubMed ID: 29872603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of neurovascular bundle formation observed on preoperative magnetic resonance imaging regarding postoperative erectile function after nerve-sparing radical retropubic prostatectomy.
    Lee SE; Hong SK; Han JH; Han BK; Yu JH; Jeong SJ; Byun SS; Lee HJ
    Urology; 2007 Mar; 69(3):510-4. PubMed ID: 17382155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurovascular bundle size measured on 3.0-T magnetic resonance imaging is associated with the recovery of erectile function after robot-assisted radical prostatectomy.
    Kwon T; Lee C; Jung J; Kim CS
    Urol Oncol; 2017 Sep; 35(9):542.e11-542.e17. PubMed ID: 28648413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
    Hoegen P; Zhang KS; Tonndorf-Martini E; Weykamp F; Regnery S; Naumann P; Lang K; Ristau J; Körber SA; Dreher C; Buchele C; Rippke C; Renkamp CK; Paul KM; König L; Büsch C; Krisam J; Sedlaczek O; Schlemmer HP; Niyazi M; Corradini S; Debus J; Klüter S; Hörner-Rieber J
    Radiat Oncol; 2022 Mar; 17(1):59. PubMed ID: 35346270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Online adaptive planning for prostate stereotactic body radiotherapy using a 1.5 Tesla magnetic resonance imaging-guided linear accelerator.
    Yang J; Vedam S; Lee B; Castillo P; Sobremonte A; Hughes N; Mohammedsaid M; Wang J; Choi S
    Phys Imaging Radiat Oncol; 2021 Jan; 17():20-24. PubMed ID: 33898773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer.
    Da Silva Mendes V; Nierer L; Li M; Corradini S; Reiner M; Kamp F; Niyazi M; Kurz C; Landry G; Belka C
    Radiat Oncol; 2021 Jul; 16(1):133. PubMed ID: 34289868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of Isotoxic Dose Escalation and Plan Quality with TDABC Analysis on a 0.35 T MR-Linac (MRL) System in Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided Radiation Therapy (MRgRT) for Primary Pancreatic Cancer.
    Hawranko R; Sohn JJ; Neiderer K; Bump E; Harris T; Fields EC; Weiss E; Song WY
    J Clin Med; 2022 May; 11(9):. PubMed ID: 35566712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Operating procedures, risk management and challenges during implementation of adaptive and non-adaptive MR-guided radiotherapy: 1-year single-center experience.
    Garcia Schüler HI; Pavic M; Mayinger M; Weitkamp N; Chamberlain M; Reiner C; Linsenmeier C; Balermpas P; Krayenbühl J; Guckenberger M; Baumgartl M; Wilke L; Tanadini-Lang S; Andratschke N
    Radiat Oncol; 2021 Nov; 16(1):217. PubMed ID: 34775998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR-Guided Radiotherapy for Prostate Cancer.
    Tocco BR; Kishan AU; Ma TM; Kerkmeijer LGW; Tree AC
    Front Oncol; 2020; 10():616291. PubMed ID: 33363041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.